Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novavax Inc. | 4 | 1 | 0 | 1 | €15.76 | €22.18 | 40.679% |
| Myriad Genetics | 4 | 3 | 0 | 0 | €25.60 | €22.15 | -13.487% |
| US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €88.00 | €108.77 | 23.601% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €10.69 | €27.02 | 152.726% |
| Edwards Lifesciences Corp. | 32 | 1 | 7 | 0 | €57.45 | €84.34 | 46.799% |
| Patterson Companies Inc. | 8 | 0 | 0 | 0 | €24.40 | €31.22 | 27.932% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.13 | - | - |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | €55.00 | €83.92 | 52.575% |
| Halozyme Therapeutics Inc. | 20 | 0 | 0 | 0 | €51.78 | €55.13 | 6.477% |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €103.90 | €109.00 | 4.909% |
| Brookdale Sr Lvg | 4 | 1 | 2 | 0 | €7.20 | €8.27 | 14.900% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.09 | - | - |
| Insulet Corp. | 17 | 0 | 0 | 0 | €178.05 | €216.46 | 21.573% |
| Masimo Corp. | 7 | 1 | 0 | 0 | €98.68 | €147.62 | 49.591% |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 2 | 0 | €8.38 | €27.83 | 232.112% |
| Smith & Nephew plc ADR | 3 | 0 | 1 | 0 | €26.20 | - | - |
| Zealand Pharma A/s | 1 | 0 | 1 | 0 | €121.00 | - | - |
| Codexis Inc. | 6 | 1 | 0 | 0 | €3.36 | €8.36 | 148.638% |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | €30.60 | €41.46 | 35.500% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €44.40 | €48.75 | 9.796% |
| Radnet Inc. | 11 | 3 | 2 | 0 | €57.50 | €58.05 | 0.953% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | €74.50 | €83.92 | 12.645% |
| Inogen Inc. | 1 | 2 | 0 | 1 | €8.95 | €6.53 | -26.989% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.36 | €3.64 | 167.971% |